Nabriva Therapeutics plc (NBRVF)
OTCMKTS: NBRVF · Delayed Price · USD
0.0001
0.00 (0.00%)
Jul 9, 2024, 9:30 AM EDT - Market closed
Nabriva Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
| Net Income | -55.05 | -57.19 | -49.45 | -69.48 | -82.76 | -114.78 | Upgrade
|
| Depreciation & Amortization | 0.1 | 0.22 | 0.64 | 0.82 | 0.77 | 0.51 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 32.05 | Upgrade
|
| Stock-Based Compensation | 1.73 | 1.97 | 3.29 | 5.22 | 9.75 | 5.15 | Upgrade
|
| Other Operating Activities | 12.52 | 4.56 | 0.82 | 3.51 | 0.55 | 0.32 | Upgrade
|
| Change in Accounts Receivable | 10.9 | 9.02 | -8.12 | -5.89 | 2.58 | 1.14 | Upgrade
|
| Change in Inventory | 8 | 4.83 | -8.69 | -5.14 | -0.68 | - | Upgrade
|
| Change in Accounts Payable | 12.95 | 1.09 | 1.58 | -1.81 | 1.31 | -2.97 | Upgrade
|
| Change in Unearned Revenue | - | -0.37 | -0.38 | 0.75 | - | - | Upgrade
|
| Change in Income Taxes | 0.38 | 0.38 | -0.01 | -0.02 | -0.07 | 0.06 | Upgrade
|
| Change in Other Net Operating Assets | -4.45 | -1.21 | 0.75 | 0.72 | -3.33 | 5.8 | Upgrade
|
| Operating Cash Flow | -12.91 | -36.71 | -59.56 | -71.33 | -71.89 | -72.72 | Upgrade
|
| Capital Expenditures | -0.12 | -0.21 | -0.03 | -0.11 | -0.06 | -0.23 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | -4.26 | Upgrade
|
| Investment in Securities | - | - | - | - | - | -0.12 | Upgrade
|
| Other Investing Activities | -0.05 | -0.05 | -0.06 | -0.16 | 0.39 | - | Upgrade
|
| Investing Cash Flow | -0.16 | -0.26 | -0.08 | -0.27 | 0.33 | -4.6 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 9.98 | 23.55 | Upgrade
|
| Total Debt Issued | - | - | - | - | 9.98 | 23.55 | Upgrade
|
| Long-Term Debt Repaid | - | -2.92 | - | -30 | - | - | Upgrade
|
| Total Debt Repaid | -6.83 | - | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -6.83 | -2.92 | - | -30 | 9.98 | 23.55 | Upgrade
|
| Issuance of Common Stock | 2.54 | 5.58 | 70.19 | 61.69 | 48.46 | 74.22 | Upgrade
|
| Other Financing Activities | -0.12 | -0.81 | -3.83 | -4.76 | -2.36 | -4.84 | Upgrade
|
| Financing Cash Flow | -4.4 | 1.85 | 66.37 | 26.92 | 56.08 | 92.92 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.43 | -0.17 | -0.48 | -0.14 | -0.11 | -0.36 | Upgrade
|
| Net Cash Flow | -17.91 | -35.3 | 6.24 | -44.82 | -15.59 | 15.23 | Upgrade
|
| Free Cash Flow | -13.02 | -36.92 | -59.58 | -71.44 | -71.95 | -72.95 | Upgrade
|
| Free Cash Flow Margin | -44.06% | -99.96% | -206.20% | -1421.21% | -758.92% | -755.51% | Upgrade
|
| Free Cash Flow Per Share | -4.24 | -13.77 | -34.36 | -139.05 | -242.43 | -359.05 | Upgrade
|
| Cash Interest Paid | 0.33 | 0.41 | 0.5 | 1.4 | 2.56 | 0.01 | Upgrade
|
| Cash Income Tax Paid | 0.15 | 1 | 0.51 | 0 | 0.01 | 0 | Upgrade
|
| Levered Free Cash Flow | 10.81 | -15.05 | -41.65 | -47.46 | -40.96 | -41.12 | Upgrade
|
| Unlevered Free Cash Flow | 11.11 | -14.61 | -41.08 | -46.43 | -38.84 | -41.04 | Upgrade
|
| Change in Net Working Capital | -39.78 | -18.1 | 14.66 | 11.02 | -0.38 | -4.98 | Upgrade
|
Source: S&P Capital IQ. Standard template.